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All eukaryotic organisms are holobionts representing complex collaborations between 
the entire microbiome of each eukaryote and its innate cells. These linked constituen-
cies form complex localized and interlocking ecologies in which the specific microbial 
constituents and their relative abundance differ substantially according to age and envi-
ronmental exposures. Rapid advances in microbiology and genetic research techniques 
have uncovered a significant previous underestimate of the extent of that microbial 
contribution and its metabolic and developmental impact on holobionts. Therefore, a 
re-calibration of the neonatal period is suggested as a transitional phase in development 
that includes the acquisition of consequential collaborative microbial life from extensive 
environmental influences. These co-dependent, symbiotic relationships formed in the 
fetal and neonatal stages extend into adulthood and even across generations.
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iNTRODUCTiON
In only a relatively few years, two complementary lines of research have intersected to dramatically 
alter our perceptions of the organizational structure of eukaryotic macroorganisms. The first of these 
is our enlarged understanding of the actual composition of all macroorganisms beyond the organic 
singularities that had been traditionally presumed. It is now apparent that all macroorganisms are 
hologenomic entities. Such organisms represent vast collaborations of mutually competitive and 
co-dependent cellular ecologies that entwine highly diverse microbial constituencies with innate 
eukaryotic cells (1–3).
The second insight is our developing appreciation of the exact expanse of this co-aligned microbial 
realm. Our prior understanding was based on microbial culturing techniques and has been widely 
expanded through contemporary genomic research and metagenomic analysis (4). This analysis has 
illuminated the astounding depth and variety of the microbial sphere with which all multicellular 
eukaryotes are linked (5). It is estimated that fewer than 10% of microbes can be cultured, and that 
may yet be an overestimate (6). This missing fraction was revealed by the analysis of 16S rRNA gene 
sequence amplification that disclosed completely unanticipated microbial lineages (7). Metagenomic 
techniques were developed to extend research beyond phylogenetic descriptions of microbial com-
munity associations. This has provided deeper insight into genetic trees, physiological mechanisms 
and has yielded the discovery of a number of novel genes and details of nutrient cycling (8). As a result, 
there is a new understanding of the commonality of horizontal genetic transfers (9–13). All of these 
contemporary findings have significant repercussions for eukaryotic growth, individual develop-
ment, and health throughout the life cycle. Consequently, the fetal and neonatal microbiomes can be 
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reappraised within this new frame and pregnancy can be viewed 
as fetal-maternal co-development. As initial background toward 
that reassessment, the origins and development of the eukaryotic 
microbiome will be reviewed, indicating an enlarged perspective 
as to its significance: the eukaryotic microbiome extends beyond 
symbiotic appendage and merits consideration as a full player in 
eukaryotic life. The experiential forces that contribute to the ori-
gins and development of the fetal and neonatal microbiome will 
then be outlined within that context. It will be presented that the 
fetal and neonatal periods represent critical stages of microbial 
aggregation and combination that have a substantial impact on 
health of the developing infant, its future well-being, and that of 
future generations.
HOLOBiONTS: AN eSSeNTiAL 
PARTNeRSHiP
It is now apparent that all multicellular eukaryotes are holobionts 
(1, 3). There are no exceptions. The extensive linkages between 
eukaryotic cells and their microbial partners in localized tissue 
ecologies maintain metabolism, the immune system, and gen-
eral balance of health that sustain eukaryotic macroorganisms. 
Until recently, our general regard of the microbial sphere was 
principally one of combat. Instead, our truer narrative is one of 
collaboration, co-linkage, and co-dependency as well as more 
obvious competition. Growing evidence suggests that recipro-
cal signaling between eukaryotic cells and their collaborating 
microbial partners significantly influences normal development 
of the eukaryotic individual (1, 14, 15). Therefore, the neonatal 
period must be considered beyond any mere coordinated innate 
series of ontological and physiological neurohumoral phases 
toward an enlarged perception. Each developmental stage of any 
life cycle across its entire arc is now understood to be dependent 
on microbial contributions that continually shift with the mac-
roorganism. The neonatal period is a meaningful stage for the 
acquisition and deployment of vital microbial partnerships, both 
as a part of a larger inter-generational developmental arc and a 
significant component of well-being throughout the remainder 
of the life cycle.
Therefore, a proper understanding of the neonatal period 
requires a reappraisal of the circumstances of macroorganic 
life. Current estimates suggest that there are at least 100 trillion 
microbes that are in and on us, including bacteria, viruses, and 
fungi. In total, they easily outnumber our primary cells by a factor 
of 10 to one or more (4, 5). The entirety of the genetic complement 
of this associated microbiome vastly outnumbers our own innate 
one (16). Although there has been a movement toward some revi-
sion of those raw numbers (17), the conclusions about the nature 
of eukaryotic multicellular organisms as functional holobionts 
remains steady.
Current research is informing us of the truer extent of the inti-
mate dependencies shared between our microbial partners and 
ourselves. In view of these interrelationships, some have consid-
ered eukaryotes as multi-species units (2) or “super-organisms” 
(18). Indeed, it is no longer tenable to regard eukaryotic mac-
roorganism as any inherent singularity. Instead, a more accurate 
perspective is that multicellular eukaryotic organisms remain 
firmly rooted within their inherent cellular nature. As vast col-
laborative enterprises of co-linked, cooperative, co-dependent, 
and competitive ecologies, these merge together so coherently as 
to seem one discrete entity. Therefore, any traditional concept of 
“host” and “guest” no longer strictly applies across this seamless 
developmental diachronic arc (3). This contemporary concep-
tualization of multicellular eukaryotic organisms displaces the 
historical notion of innate “us” and conjoined microbial life as 
“other” into a modern appraisal of an organic entity that is a 
consensual “we.” All evolutionary development of all eukaryotic 
macroorganisms is derived from unicellular roots and remains 
perpetually anchored within cellular processes and conditions 
(19–23). Consequently, growth and development of all macroor-
ganisms can now be appropriately viewed within a firmly cellular 
trajectory. Therefore, the neonatal period can be represented as 
one crucial stage of temporal variation of these mixed cellular 
ecologies that must perforce exist within immunological rules (3).
THe MiCROBiOMe iN HeALTH  
AND DiSeASe
Current research is revealing that our reproductive potential, 
developmental stages, immune system, and metabolism are a 
coalescence of both innate cellular and microbial traits (4, 14). 
The microbiome is the vast numbers and varieties of microbes, 
their genes, and their metabolites that are embedded features of 
all mucosal surfaces, digestive tract, skin, and all bodily tissues. 
Each assemblage plays a critical role for the optimal function of 
our gut (24), brain and central nervous systems (25, 26), respira-
tory (27) and immune systems (28, 29), and oral cavity (30).
Our understanding of the range of influences of the microbial 
sphere in each of these cellular ecologies as well as their extensive 
networks of interconnections continues to enlarge. The gut 
microbiome is a critical determinant of both innate immunity 
and adaptive immune systems of all eukaryotic macroorganisms 
at all stages of life (31). For example, intestinal dysbiosis with a 
breakdown of homeostatic balance of a healthy gut microflora has 
been linked to inflammatory bowel disease and susceptibility to 
enteropathogens (32, 33). Significant gut dysbiosis has also been 
linked to metabolic syndrome and obesity (34), and can have a 
profound influence on the CNS (26). Studies have demonstrated 
that changes in the gut microbiome can substantially alter brain 
function and behavior through neural, endocrine, and immune 
pathways. In a similar manner, the respiratory system is now 
understood to have its own intricate ecological microbiome, 
analogous to the gut microbiome, whose equilibrium must be 
maintained to resist bacterial overgrowth and the development 
of respiratory infections (35).
It has been estimated that at least 30% of mammalian metabo-
lites have a bacterial origin. Approximately 37% of human genes 
have with homologs in Bacteria and Archaea of which 28% are 
estimated to have originated in unicellular eukaryotes (15). 
The intrinsic metabolic drive of all complex organisms is sup-
ported by a variety of microbial participants. One crucial aspect 
of these specific microbial balances within each tissue ecology 
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is the protection against pathogens that grants survival. For 
example, bifidobacteria provide protection in the gut from enter-
opathogenic infection through production of acetate (36). These 
interrelationships are so overlapping and co-dependent that any 
individual eukaryotic organism must be viewed as intertwined 
ecological co-dependent cellular habitats. In this complex asso-
ciation, fundamental processes of community ecology apply, such 
as dispersion of nutrients and constituents, degree of variation 
and specialization, or selection pressures (28).
vARiATiONS wiTHiN THe HUMAN 
MiCROBiOMe
Characteristics of the Microbiome among 
Species and individuals
Research has demonstrated that microbiomes remain similar 
within species though subject to wide variation of the exact mix 
and match (37). Nevertheless, surveys of human gut microbial 
ecologies suggest that these microbiomes can be pertinently clas-
sified within broad “enterotypes” based on the varied abundance 
of an expanse of microbial constituents derivative of ancient 
mammalian microbiomes (38). This would not be surprising 
since the inheritance of bacterial DNA and bacteria by epigenetic 
mechanisms are now well established (39). Further yet, the impact 
of the virome is just as significant (40), and is now understood 
to be a consequential component of human ecosystems, includ-
ing its evolutionary development (41). For example, LTR class 
I endogenous retrovirus (ERV) retroelements, a distant relative 
of HIV, has considerably impacted the transcriptional network 
of human tumor suppressor protein p53 (42). This is a master 
gene regulator crucial for primate differentiation. Therefore, 
retroelements are one significant component of the evolutionary 
development of the regulatory network of transcription factors in 
a species-specific manner.
Recent investigations have been directed toward identifying 
a general core human microbiome. As such, the concept of a 
minimal obligatory gut metagenome in functional terms is now 
regarded as a feature of human life and is a consequential aspect 
of its health and development (43). Metagenomic sequencing 
of the human gut has demonstrated a microbial gene set that is 
more than 150 times larger than the innate human gene cohort. 
At least 1000 bacterial strains have been identifiable, which are 
largely shared among all humans (44). A survey of 18 body sites 
in over 200 individuals has demonstrated general stability of 
the microbiome among greater than 95% of participants (45). 
Interestingly, it was the vaginal microbiome that demonstrated 
the least commonality. Even within that localized variation, the 
dominant microbial contribution was the Lactobacillus genus 
with a considerable variation of sub-genus types. In general, Huse 
et al. have found that the human microbiome sticks to type, even 
with respect to the neonatal birthing experience (45).
While it now seems to be true that the microbiota has general 
stability among individuals of the same species, an integrated 
survey of its spatial and temporal distribution demonstrates 
significant complexity. In any given individual, the microbiota is 
personalized and has significant spatial variability across body 
habitats (46). Furthermore, systematic temporal variation has 
also been revealed. It seems likely that the pace of this temporal 
variation, though life long, is greatest from the fetal state extend-
ing across infancy.
Temporal variation of the Fetal and 
Neonatal Microbiome
Research is now indicating that the fetal stage has a substan-
tial influence on the microbiome of the neonate and beyond. 
Although it has long been believed that the uterus, amniotic fluid, 
and the fetus are sterile, this has been an incorrect assumption. It 
is now apparent that the placenta harbors a unique microbiome. 
This is characterized by non-pathogenic commensal microbiota 
from the Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, 
and Fusobacteria phyla that most closely resembles the maternal 
oral microbiome (47). The ramification has been the demonstra-
tion of in utero colonization of the infant gut (48, 49). Microbes 
can be identified in meconium, predominantly belonging to 
the Enterobacteriaceae family along with lactic acid bacteria, 
including Leuconostoc, Enterococcus, and Lactococcus (48, 
50). This microbial profile strongly resembles that of young 
infants, but importantly is significantly influenced by a range 
of maternal factors. For example, maternal eczema has been 
linked to newborn respiratory disorders (51). Therefore, there 
is a necessary overlap of the maternal immune system with that 
of the fetus and this extends beyond the direct innate maternal 
mechanisms that were previously assumed to be the only opera-
tive ones.
The ongoing development and maturation of the neonatal 
gut microbiota, and presumably then every other localized 
microbiome of any neonate, is affected by numerous factors that 
represent a developmental arc extending from mother to child. 
This includes maternal diet or weight gain, probiotic use, pre-
natal, peri-natal, or post-natal antibiotic use, mode of delivery, 
or feeding regimen (52). These influences can be significant and 
last across childhood and also carry the potential to affect the 
entire adult life cycle. For example, C-section delivery altering the 
normal exposure to vaginal microbiome has been associated with 
an increased risk of celiac disease, Type 1 diabetes, asthma, and 
obesity (53). Maternal antibiotic use has been linked to an 84% 
increase in childhood obesity and a significant increase in asthma 
that can continue into adulthood (53).
Through profiles of vaginal and milk samples, maternal and 
paternal stool samples, and metagenomic samples from siblings, 
it has been demonstrated that microbial communities vary widely 
from baby to baby based on all sources. There are considerable 
temporal variations, each with distinct features, that range across 
weeks to months (54). However, by the end of the first year, most 
of these idiosyncratic microbial ecologies tended to converge 
toward a characteristic adult profile in a non-random pattern of 
succession (55). Even given those changes, the infant at 11 months 
remains its own individual with phylotypes that can be distinct 
from the mother (56). A strong resemblance of a typical adult gut 
microbiome does not ensue until 2–3 years of age with specific 
assemblages demonstrating geographically based population 
differences (57).
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Mode of delivery and feeding regimen appear to have large 
initial influences on this variation. The highest incidence of 
advantaged infant gut microbial ecology (defined as the high-
est counts of bifidobacteria and lowest numbers of Clostridium 
difficile and Escherichia coli) among term infants born vaginally 
and exclusively breast-fed (58). Vaginal delivery promotes colo-
nization by maternal vaginal and fecal bacteria (Lactobacillus, 
Bacteroides, Fusobacteria), whereas infants born by cesarean 
section have a greater number of microbes associated with skin 
and the hospital environment (Staphylococcus, Corynebacterium, 
Propionibacterium) (48, 59). Comparisons between breast or 
formula-fed infants show larger populations of Bifidobacterium 
and Lactobacillus among those that were breast-fed and greater 
numbers of C. difficile, Bacteroides, Streptococcus, and Veillonella 
among the formula-fed cohort (48). These microbial shifts may 
account for the association of impaired development of the 
neonatal immune system and altered metabolic parameters later 
in life when infant formula-feeding is substituted for breast-
feeding (53).
HeRiTABLe ASPeCTS OF THe HUMAN 
MiCROBiOMe
Over the last two decades, there has been a critical reappraisal of 
previously discredited Lamarckism toward an increasing accept-
ance of the impact of the heritable nature of acquired characteris-
tics (60–62). Such heritable overlaps between parent and child are 
much more complex than previously imagined. Sampling of the 
placenta and amniotic fluid demonstrates bacteria representative 
of the maternal gut and oral microbiomes whose mechanism 
of transfer is unknown; it is postulated that the transmission 
travels via lymphatic networks for the gut (63) or the blood 
stream secondary to gingival inflammation (64). Although the 
heritable transmission of symbionts has been known to occur in 
invertebrates for over 50 years, it had remained controversial in 
humans and other mammals until recently (49). The mechanisms 
of transfer are both internal and external and the mechanisms are 
not always clear in either case (1, 2). For example, breast milk, 
though long thought sterile, actually has hundreds of bacterial 
strains that vary over the course of lactation (65, 66).
Such transfers are now believed to carry a range of conse-
quences that are greater than any simple sharing of microbial 
types. It is now contended that there is sufficient developmental 
and phenotypic plasticity to permit an organism to adjust its 
phenotype and that of its offspring in direct response to the 
environment (67, 68). The heritable microbiome is part of that 
reciprocating system. Heredity extends beyond parental genes to 
encompass the heritable transmission of extensive developmental 
resources between parent and offspring. The trajectory of an 
organism is thereby shaped by adjustments by both internal and 
external influences along developmental paths.
A better understanding of this type of interplay can be gained 
through the concept of niche construction theory. This holds 
that an organism is not only influenced by its environment but 
also reciprocally influences it. For example, in the macro sphere, 
earthworms chemically alter the soil, but in so doing, also provide 
themselves with an environment in which their renal function is 
optimally suited. In this manner, they improve their own fitness 
and then indirectly provide a similar service to other proximate 
species (69). Adaptation is also a reciprocating process, in which 
an organism participates in ameliorating some of its selection 
pressures within local environments. Therefore, it can be repre-
sented that this reverberating interchange also occurs between 
the microbial sphere and our innate cellular composition in a 
continuous enactment of mutual niche construction at a cellular 
level, as a mirror image of similar processes in the macro envi-
ronment. This reciprocating interaction is an important aspect 
of the development of any organism and extends across our life 
span. Yet, it is reasonable to suppose that it is most consequential 
during the developmental phases of any macroorganism. As such, 
the full range of development of any organism can now be better 
understood as a product of a combination of discrete heredity, 
its collaborating microbial consort, environmental impacts, and 
heritable genetic transfers. Each of these is always in reciprocation 
with the others and the outward environment. This perspective 
empowers a new understanding of ourselves as a continuous pro-
cess of organism–environmental complementarity that extends 
across our life spans and even beyond.
Within such a framework, Gilbert proposes a “re-tell” of the 
human birth narrative. In these terms, birth is the origin of a new 
community (70). It is not merely the eukaryotic body that is being 
reproduced, but a set of overlapping and complex microbial/
eukaryotic cellular symbiotic relationships. Therefore, pregnancy 
may be due, in part, to these symbiotic interrelationships in 
which the fetus has its own reciprocating microbial community. 
The immune mechanisms between mother and fetus are thereby 
influenced and modulated by a set of countervailing responses 
from the entire microbiological cohort that participates.
THe iMPACT OF THe MiCROBiOMe  
ON DeveLOPMeNT
All of these factors permit the reappraisal of the neonatal period. It 
can be viewed as the reciprocating intersection of an overarching 
maternal influence on the dynamics of the multi-source accre-
tion of a neonatal microbiome that is significant for its develop-
ment. In essence, pregnancy and birth are co-development with 
interlocking niche construction and the “passage from one set 
of symbiotic relationships to another” (70) (p.1). It is suggested 
that the best means through which this might be conceptualized 
is a form of “host” scaffolding in which microbial constituents 
colonize a eukaryotic organism. Chiu and Gilbert reinforce 
this same point (18). They argue that the relationship between 
humans as holobionts and our essential microbial fraction is an 
instance of reciprocal scaffolding, developmental mutualism, and 
ecological niche construction. In such circumstances, mother 
and fetus and their respective symbionts constitute the condi-
tions for the development and reproduction of the other. These 
reciprocal relationships include the direct induction of both 
maternal and neonatal physiological changes so that ecological 
relationships within varying tissues are changed. Crucially, since 
this process begins before birth and then continues thereafter, it 
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is not surprising that changes in the maternal microbiome are 
now being linked to a variety of differing pregnancy outcomes 
and pre-term birth (71).
When neonatal development is considered within such 
an enlarged holobionic frame, the widespread and enduring 
influence of epiphenomena impacting mixed cellular/microbial 
ecologies in full-term infants can be better understood. Persistent 
cognitive abnormalities in malnourished children are linked, in 
part, to a persistent pattern of immature gut microbiota; specific 
regions of the brain exhibit persistent neotenous patterns of 
gene expression associated with later deficits in higher cognitive 
functions. It is believed that the brain has been made vulnerable 
by gut dysbiosis induced by malnutrition (72). In this manner, 
it is suggested that the development of the microbiome in the 
neonatal period and infancy should be considered as a developing 
“microbial organ.” The gut flora is recognized as having a collec-
tive metabolic activity equal to a “virtual organ within an organ” 
(73). It also becomes clear that the development of that “organ” is 
a function of a significant overlap with the maternal microbiome. 
For example, Gosalbes et  al. used culture-independent genetic 
screening to demonstrate a high incidence of maternally trans-
ferred antibiotic-resistant genes in infant’s meconium and fecal 
samples, at least some of which is presumed to have occurred 
in utero (51).
Therefore, the critical aspect of the microbial cohort of every 
holobiont must now be considered in explicit developmental 
terms along its long arc of life, beginning before conception. 
Multiple tissue ecologies function both at an individual level 
and collectively as part of a combined set of coordinating mixed 
cellular/microbial constituencies that comprise any eukaryotic 
multicellular organism. In such circumstances, it is implicit that 
any such understanding must fully appraise the overlapping 
sources of all superimposed localizing environmental influences 
of all types (67, 68).
New PeRSPeCTiveS ON THe  
NeONATAL MiCROBiOMe
Since all eukaryotic multicellular organisms are holobionts, our 
viewpoint of development can now be re-framed. The complex 
collaborative partnerships that enable all multicellular eukaryotic 
life exist across an entire developmental landscape that is inher-
ently enacted at the microscopic level rather than the more easily 
assessed macroscopic one (3). As Gilbert points out, “Some mate-
rial in the mother’s milk is for the bacteria and not the infant.” (70) 
(p.5). Maternal milk sugars intersect with the newborn immune 
system in one stage of its developmental arc to enable the suc-
cessful reproduction of a particular set of bacteria. In reciprocity, 
that bacterial strain and others can then enable the diachronic 
unfolding of developmental capacities of the infant.
Given these overlaps, some have suggested that a mental 
picture of a core microbiome might be likened to a Venn dia-
gram with overlapping circles that indicate the membership of a 
sample within human habitats (74). Yet, any such diagram misses 
a vital point. Holobionts are flux agencies in which ecological 
partnerships vary over time as a crucial shifting balance between 
innate cells and a variable as well as an obligatory co-aligned 
microbiome.
These complexities point to the probability of a long journey 
of discovery about these necessary co-dependencies. It is now 
acknowledged that the outward universe cannot now be properly 
framed outside of the existence of dark matter that has only 
recently been validated. Our genomes cannot be currently under-
stood absent the “junk” DNA that is no longer considered such 
(75–78). Similarly then, it is likely that the boundaries between 
what has been termed facultative microbial life and that which is 
currently defined as obligate will also undergo very substantial 
modification in the future (79, 80). It is likely that the meaning 
of commensal, mutualist, and symbiont will evolve over time. In 
fact, as our understanding enlarges, a change in terminology may 
be required to reflect these consequential differences. Commensal 
bacteria are recognized mutualists that supply a eukaryote with 
essential nutrients by assisting in the metabolism of otherwise 
indigestible compounds. Importantly too, they form a constitu-
ency that unites with innate cells, such as gut mucosa, to defend 
against super-infections by potential pathogens, such as C.  difficile 
(81). Yet, the difference between a “good” microbe and a “bad” 
one can become blurred; some types of normal gut bacteria can 
become pathogenic, in which they are termed a “pathobiont” (29). 
In such circumstances, it is not easy to sort with any exactitude 
the means by which intestinal dysbiosis leads to dysfunction of 
the adaptive immune system or inflammatory bowel disease. The 
complexity of these interrelationships is so great that Round and 
Mazmanian (29) have even raised the possibility that the mam-
malian immune system is controlled by microorganisms and has 
not been devised to control them as always presumed.
iNTeRveNTiON iN THe NeONATAL 
MiCROBiOMe
There are many advantages to reconsider the exact circumstances 
of the neonatal period. A fuller perspective of the conjoined 
and overlapping developmental arcs of the maternal and fetal 
microbiomes improves opportunities for intervention. Studies of 
the microbial status of the placentas of pre-term infants predict 
white matter damage and later cerebral palsy (82). Certain pre-
natal placental microbial patterns that are specifically associated 
with infection from maternal skin microflora presage echo-
lucent lesions, ventriculomegaly, and diparetic cerebral palsy. 
Furthermore, it appears that the pre-term infant gut microbiota is 
different from that of term infants. Pre-term infants demonstrate 
a much larger inter-individual variation than among healthy full-
term infants, thereby suggesting an opportunity for protective 
adjustment (83). For example, although no specific pathogen has 
been identified as a direct causal factor in necrotizing enterocol-
itis (NEC), a low diversity of specific gut microbial constituencies 
has been determined in pre-term infants with NEC compared to 
full-term controls (84). In infants likely to go on to NEC, a sub-
stantial increase in Proteobacteria and a decrease in Firmicuties 
within the first week of life was detected (85). Importantly, it 
seems that pre-natal influences are consequential in this general 
dysbiosis. The result has been considered a dysmature response 
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to microbial colonization with a resultant breach of the intestinal 
epithelial barrier involving a breakdown of intestinal immune 
homeostasis (86, 87).
The potential of these types of interactions is far-ranging. 
Reciprocating developmental relationships form a rich gut–brain 
axis that provides potent linkages between neonatal sepsis and 
NEC with long-term psycho-motor disabilities (88). Attempts 
to ameliorate this are already underway. There are now several 
interventions being studied in pre-term low birth weight infants 
through the prophylactic administration of specialized prebiotics 
and probiotics. This approach seems to offer a tantalizing hope 
that gut microbial dysbiosis is amenable to manipulation and a 
decrease in the incidence if NEC (89, 90).
Nor is the neonatal gut, the only microbiome of consequence. 
Microbial dysbiosis in the neonatal lung includes aspects similar 
to that of the gut and has shown an association with the incidence 
of bronchopulmonary dysplasia (BPD). A reduced diversity of 
the neonatal lung microbiome may be a significant factor in the 
subsequent development of BPD that is independent of immune 
mediators and cytokine levels (91). Furthermore, research is 
demonstrating a highly complex and little-understood interplay 
between the development of neonatal gastrointestinal and res-
piratory microbiota and the subsequent regulation of immune 
function (92). Similarly, the neonatal and infant skin microbiome 
has only recently been explored in any detail. It is now known 
that the skin microbiome is transiently influenced by mode of 
delivery but evolves rapidly over the first year of life, demonstrat-
ing steadily increasing microbial diversity (93). The exact role of 
this temporal variation of the evolving infant skin microbiome in 
protection against pathogens or the modulation of the immune 
system is yet unclear though certainly important. It is possible 
that the skin microbiome directly influences the correct develop-
ment of the epidermis after birth (94). Recent research has dem-
onstrated that the microbiome extends below the epidermal layer, 
again emphasizing the presence of active microbial colonization 
and ecological interplay at a site that had always been presumed 
sterile (95).
Therefore, properly adjudicating this passage can be expected 
to have substantial impacts on neonatal health that extends into 
childhood and adult life. Disturbance of the acquisition of any 
desirable microbial fraction, either from maternal influence or 
mode of delivery (96), can now be linked from this transitional 
phase to subsequent diverse childhood and adult outcomes that 
encompass allergic status (97, 98) and obesity (99). For example, 
investigations have demonstrated possible associations between 
maternal or neonatal administration of antibiotics and the 
subsequent development of childhood and adult allergies and 
asthma (100–102).
There are other aspects of life-long repercussions of cellular/
microbial relationships that would have been considered remote 
until recently. Microbial partnerships mediate the physiology 
of all eukaryotic organisms and actively participate in a wide 
range of neurodevelopmental capacities. Experiments with mice 
have demonstrated diminished motor activity and an increase 
in anxiety-like behavior when the gut microbiota is suppressed 
(26). This is associated with altered gene expression patterns 
and appears to involve messaging pathways that affect neuronal 
circuits. The microbiota–gut–brain axis, as an emerging concept, 
has been linked to altered brain development and behavior, 
neurodevelopmental disorders, and autism (103). Experiments 
with gut-microbiota-suppressed mice demonstrate significant 
social impairment. It is apparent that microbiota has a role in the 
programing of normal species social behaviors. A fuller under-
standing of these gut–brain interrelationships is now indicating 
a role for the microbiota as an unconscious system regulating 
behavior. Such impacts have been seen on cognitive function, 
stress management, and diverse neurodevelopmental patterns, 
such as autism spectrum disorders (104, 105). Therefore, thera-
peutic manipulation of the enteric microbiome is actively being 
investigated (106). Furthermore, increasing research into epige-
netic mechanisms indicates the substantial potential for these 
types of consequences to reverberate back and forth between 
generations in complex skeins not imagined until only a very few 
years ago (11–13).
Although it is clear that the neonatal period is necessary for the 
acquisition, succession, and development of a robust microbial 
fraction of hologenomic life, there is never any explicit endpoint 
while living. Even in adulthood, the spectrum continually shifts, 
subject to epiphenomena, such as antibiotic treatments, dys-
biosis, obesity, and environmental impacts. Indeed, the oppos-
ing end of the life spectrum, a consistently shifting “elderly” 
microbiome may have its own consequential impact reciprocal 
to our understanding of the temporal variation that characterizes 
infancy (107).
Indeed, the essential consideration is that the very concept 
of host, obligate mutualist, opportunistic symbiont, parasite, or 
pathogen must be entirely re-explored across an entire life cycle. A 
requirement for optimal intervention then becomes the detailed 
understanding of all the specifics of the human microbiome. This 
is particularly so for the neonatal period in which continuous 
epigenetic changes and shifts are occurring in both obligate and 
facultative microbial assemblages in continuous reciprocity with 
the environment (108).
It is now becoming increasingly evident that substantial pro-
gress toward the successful treatment of many diseases will be 
dependent upon a much deeper understanding of the temporal 
relationships of the human microbiome. This seems especially 
the case for many chronic afflictions, such as inflammatory 
bowel disease, obesity, and some mood disorders (109–111). That 
complexity can begin to be unraveled by emerging sequencing 
capacities and computational technologies. There is a reciprocal 
side to any such exploration. A full understanding of human 
health requires an appreciation of a life-long arc of individual 
temporal variation of a personalized microbiome that represents 
a continuum of individual proclivities, cultural milieu, and 
parentage. Any in-depth understanding of the neonatal period 
and its developmental processes and metabolic status requires an 
assessment of foods, medications, and individual immunological 
capacity, including adaptive experiences of both child and parent. 
This becomes an appraisal of a full panoply of pertinent informa-
tion beyond the traditional scope. It would be a happy occurrence 
if all these shifts of any minimal microbiome might yield direct 
and simple analysis toward treatments. Yet, that is likely not. 
It is becoming ever clearer that idiosyncratic characteristics of 
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the entirety of all holobionts both unite us as a species but still 
separate us from all others like ourselves. The future of medicine 
will need to accommodate this complex individuality.
It is pertinent to note that progress toward that specific goal will 
need a much greater degree of standardization of the techniques 
for sample gathering and analysis of the microbiome than prior 
studies. These have been understandably constrained by the diffi-
culties inherent in obtaining and sampling microbial communities 
in any tissue ecology in a reproducible manner so that results can 
be fruitfully compared. Recent research studies have attempted to 
address these sources of error (112, 113). In these reports, stool 
samples were immediately frozen by the participants and picked 
up by investigators instead of being sent in by mail. Consequently, 
there was a high level of concurrence between the analytic find-
ings in both of these studies. Additionally, a very broad range 
of markers and environmental factors was considered, including 
known diseases, drug usage, multiple smoking categories, and 
extensive dietary factors. Such meticulous techniques will be a 
requirement going forward. However, even this will represent a 
continued significant limitation until it can be applied beyond the 
bacterial domain with similar scrupulous analysis extended into 
associated viral and fungal constituencies.
Even given these variables, there will be substantial progress. 
The contemporary realization that our modern metabolism 
has evolved via serial exaptations from cellular roots has an 
increasingly direct bearing on current medical practice. It will 
also explicitly pertain to future productive research in human 
physiology, metabolism, and immune function (20, 22, 23). It is 
a cellular world, dominated by cellular imperatives, reiterated in 
local and shared cellular ecologies to enact macroorganisms that 
to our superficial appraisal are singular but decidedly, are not. 
Therefore, the applicable drama ever and always dwells within 
a cellular realm dominated by immunological rules by which 
eukaryotes actually live (3).
CONCLUSiON: A vAST FRONTieR
Intersecting recent discoveries confirm that there is an arc of 
associated microbial and innate cellular interactions that engage 
as holobionts and extend beyond any traditional age-related 
touchstones of intrinsic neurohumoral development. Within 
this frame, each eukaryotic macroorganism is now known as a 
complex collaboration of mixed cellular and microbial ecologies 
constituted by the entirety of its innate cells and its associated 
and shifting microbiome. Therefore, our understanding of devel-
opment must incorporate an unfolding narrative of microbial 
aggregation and disassembly in concert with our innate cells. 
Collectively, these elaborate the metabolic stream that promotes 
development and governs our life cycle. This naturally extends 
across the attainment of reproductive ability and proceeds then 
inevitably to senescence and death. Within this entire arc, the 
neonatal period is an active crossroad. It is within this temporal 
phase that critical interrelationships are formed and it can be 
asserted that these ever govern that arc. They begin with invisible 
threads even prior to the zygotic stage, are nurtured and adju-
dicated in the womb, and extend beyond individual life itself as 
either epigenetic shadow or privilege in the generations beyond.
The manner in which the neonate meets and accommodates 
this interplay will in many respects settle the future of the adult 
organism (114). Plainly then, a major frontier in neonatology 
is the far-reaching and still little explored interstices of this arc 
of conjoined life. As properly appraised, the neonatal period 
becomes a crucial stepping stone toward either future advantage 
or debility, … ever and always, for better or worse, securely 
anchored to both its immediate and ancient past.
GLOSSARY
Microbiome – The complete set of microorganisms in a particular 
environment.
Hologenome – The sum of the genetic information of the 
innate cells of an organism and its entire associated microbiome.
Holobiont – A macroorganism representing a combination 
of its innate cells and entire microbiome, i.e., all multicellular 
eukaryotic macroorganisms.
Metagenome – All the genetic material present in an environ-
mental sample.
Epigenetics – Heritable changes in gene expression not due to 
changes in the underlying DNA code. Anything other than innate 
DNA sequences that influences the development of an organism.
Niche construction – The process by which an organism 
interacts with and alters environments, generally in a manner that 
increases its chances of survival.
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